retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 vs Semaglutide: vs Single Comparison - Which Is Better? | PPW Retatrutide Phase 2 NEJM Trial:
Description
doi: 10.1210/edrv-16-3-390

Both drugs commonly cause nausea, vomiting, and diarrhea
About half of all users stop taking GLP-1s within a year and 75% have stopped after two years, likely due to side-effects, such as nausea, and the overall cost involved

After eating, our cells take in glucose from the bloodstream and use it to fuel essential activities
Both GLP-1 and GIP have been shown to regulate appetite and enhance memory formation with a high expression of GIP in neurons within the hippocampus, olfactory bulb, and Purkinje cells of the cerebellum [100]

doi: 10.1021/acs.jmedchem.5b00726, 88 le RouxC
